Mustang Bio MBIO
NASDAQ MBIO
$0.48 +0.01 (+2.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Mustang Bio (MBIO) Non Operating Investment Income (2023)

Updated

Mustang Bio (MBIO) posted Non Operating Investment Income of $115,000 for Q4 2023, down 91.5% from the prior quarter.

Analysis

Mustang Bio (MBIO) Non Operating Investment Income (2023) Analysis & Trends

For FY2023, Mustang Bio's Non Operating Investment Income came in at $1.47 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Mustang Bio 3.23 Mn 3.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 115,000.00
Sep 30, 2023 1.35 Mn
API Access

Mustang Bio Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MBIO&period=max&api_key=YOUR_API_KEY